Feed aggregator

Journal of Vascular Surgery – April 2019 Audiovisual Summary

Journal of Vascular Surgery - March 31, 2019 - 23:00
Welcome the April issue of the Journal of Vascular Surgery. We have four outstanding papers for you to read for free, as well as many other outstanding papers.

Events of interest

Journal of Vascular Surgery - March 31, 2019 - 23:00
News items of interest to the vascular surgeon must be received at least 8 weeks before the desired month of publication. Announcements published at no charge include those received from a sponsoring society of this Journal, those courses and conferences sponsored by state, regional, national, or international vascular surgical organizations, and university-sponsored continuing medical education courses. Send applicable events to Andrew O’Brien, Journal Manager, at a.obrien@elsevier.com. All other news items selected for publication carry a charge of $60.00 US for each insertion, and the fee must accompany the request to publish.

Information for readers

Journal of Vascular Surgery - March 31, 2019 - 23:00
Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 603-523-2222; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors should consult this document before submitting manuscripts to this Journal.

Contents

Journal of Vascular Surgery - March 31, 2019 - 23:00

Editorial Board

Journal of Vascular Surgery - March 31, 2019 - 23:00

Correction

Journal of Vascular Surgery - March 31, 2019 - 23:00
In the February 2019 issue of the Journal of Vascular Surgery, the article by Bleyer et al (Bleyer AJ, Scavo VA, Wilson SE, Browne BJ, Ferris BL, Ozaki CK, et al. A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis. J Vasc Surg 2019;69:507-15) contained a typo in the manufacturer name of VasCore. The correct name is VasCore and not VasCare as published.

Hemodialysis access creation episode-based cost measure

Journal of Vascular Surgery - March 31, 2019 - 23:00
The Medicare Access and Children's Health Insurance Program Reauthorization Act (MACRA) established the Quality Payment Program. The Quality Payment Program requires providers who bill Medicare to participate in the Merit-based Incentive Payment System (MIPS) or an Advanced Alternative Payment Model. Most vascular surgeons will participate in MIPS as no Advanced Alternative Payment Model is approved for vascular surgery. Failure to participate adequately in MIPS in 2019 will result in a 7% penalty in 2021 reimbursements.

Correction

Journal of Vascular Surgery - March 31, 2019 - 23:00
1/6/2018

Weekend Effect in Carotid Endarterectomy

Journal of Vascular Surgery - March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2018.

Strategy for the Treatment of Spontaneous Isolated Visceral Artery Dissection

Journal of Vascular Surgery - March 31, 2019 - 23:00
This was a single-center retrospective review from 2005 to 2016.

Antiplatelet Therapy for Peripheral Artery Disease

Journal of Vascular Surgery - March 31, 2019 - 23:00
A review was conducted of registries, randomized trials, and meta-analysis publications from PubMed between 1994 and 2018 and on-line clinical trials in 2018.

Hospital Volume Matters: The Volume-Outcome Relationship in Open Juxtarenal AAA Repair

Journal of Vascular Surgery - March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2016.

A Systematic Literature Review of Patients with Carotid Web and Acute Ischemic Stroke

Journal of Vascular Surgery - March 31, 2019 - 23:00
A search was conducted of MEDLINE through PubMed (1946-December 15, 2017), Embase through Ovid (1947-week 50, 2017), and the Cochrane Library through Wiley (ending December 15, 2017).

Reply

Journal of Vascular Surgery - March 31, 2019 - 23:00
We appreciate the excellent comment by Botes et al. The highlighted improvements in abdominal aortic aneurysm (AAA) repair in the United Kingdom give evidence of the value of real-world data use, and the authors should be congratulated for being a part of this outstanding success of ongoing changes in vascular services in Great Britain. Widespread adoption of endovascular aneurysm repair (EVAR)1,2 and the ongoing centralization of AAA repairs3,4 can be seen as the cause of improvements in both intact and ruptured AAA repairs.

Regarding “Impact of weekend treatment on short-term and long-term survival after urgent repair of ruptured aortic aneurysms in Germany”

Journal of Vascular Surgery - March 31, 2019 - 23:00
Behrendt et al1 should be congratulated on their work identifying worse in-hospital survival rates for patients treated for ruptured abdominal aortic aneurysm (rAAA) at the weekend in Germany. The “weekend effect” has received much attention since 2001, when it was first described in a population of Canadian patients undergoing repair of rAAA.

A systematic review and meta-analysis of the comparison of performance among step-tip, split-tip, and symmetrical-tip hemodialysis catheters

Journal of Vascular Surgery - March 31, 2019 - 23:00
Patients with end-stage renal disease need vascular access to ensure sufficient blood flow during hemodialysis (HD). Patients who are poor candidates for arteriovenous access creation require long-term catheter placement. Problems such as dialysate recirculation, thrombosis, catheter-related infections, and malfunction can occur with HD catheters. Different tip designs (step, split, and symmetrical) have been developed to ameliorate the catheter-related problems. The aim of the study was to compare the efficacy and safety of split-tip, step-tip, and symmetrical-tip HD catheters.

Transcaval embolization as the preferred approach

Journal of Vascular Surgery - March 31, 2019 - 23:00
The management of type II endoleaks that develop after endovascular repair of aortic aneurysms now includes the transcaval approach. We reviewed the safety and efficacy of this technique in 10 consecutive patients (82 ± 7 years old; 80% male) who presented with a mean sac enlargement of 1.2 ± 0.7 cm and documented flow within the aortic sac. Patients presented a mean of 5.5 ± 3.1 years after endovascular aneurysm repair, and five (50%) patients had prior attempts at endovascular repair of the documented endoleak.

Invited commentary

Journal of Vascular Surgery - March 31, 2019 - 23:00
In this issue of the Journal, Tsilimparis et al report on the largest clinical experience with endovascular aortic arch repair using branched endografts in the Western world. The study highlights the evolution of stent graft design, its patient selection, and the use of a multidisciplinary approach towards open and endovascular techniques in a single center. Overall, endovascular treatment was selected in 30% of 430 patients with aortic pathology, including inner branched devices in 54 patients (13%), fenestrated devices in 46 (10%), and parallel stent grafts in 30 (7%).

The rise and fall of beta-blockers?

Journal of Vascular Surgery - March 31, 2019 - 23:00
The study reported by Shannon and coworkers identified that preprocedure beta-blocker therapy was associated with an increased risk of major adverse cardiovascular events (MACEs) in patients undergoing either open surgery or endovascular therapy for chronic limb-threatening ischemia. The authors reviewed 11,785 revascularization procedures using the National Surgical Quality Improvement Program. There are several limitations to the study acknowledged by the authors, such as the absence of knowledge regarding the type, dosage, and duration of the beta-blocker therapy as well as follow-up limited to 30 days.
Syndicate content